Evidence map›Paper›PMID 25775225›Full record

Trial reportSubstance abuse2016

Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.

Douglas L Polcin, Rachael Korcha, Jason Bond, Gantt Galloway, Madhabika Nayak

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Substance abuse, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Douglas L Polcina Alcohol Research Group , Emeryville , California , USA.
Rachael Korchaa Alcohol Research Group , Emeryville , California , USA.
Jason Bonda Alcohol Research Group , Emeryville , California , USA.
Gantt Gallowayb California Pacific Medical Center , San Francisco , California , USA.
Madhabika Nayaka Alcohol Research Group , Emeryville , California , USA.
Alcohol Research Group · USCalifornia Pacific Medical Center · US

Funding

Intensive Motivational Interviewing for Methamphetamine DependenceR01DA024714 · NIDA · PUBLIC HEALTH INSTITUTE · PI POLCIN, DOUGLAS L · 2009 to 2013
$2.8M
NIDA NIH HHS R01 DA024714NIDA NIH HHS R01DA024714
6 · The paper itself

Abstract

backgroundFew studies have examined how changes in psychiatric symptoms over time are associated with changes in drug use and severity of drug problems. No studies have examined these relationships among methamphetamine (MA)-dependent persons receiving motivational interviewing within the context of standard outpatient treatment.

methodsTwo hundred seventeen individuals with MA dependence were randomly assigned to a standard single session of motivational interviewing (MI) or an intensive 9-session model of MI. Both groups received standard outpatient group treatment. The Addiction Severity Index (ASI) and timeline follow-back (TLFB) for MA use were administered at treatment entry and 2-, 4-, and 6-month follow-ups.

resultsChanges in ASI psychiatric severity between baseline and 2 months predicted changes in ASI drug severity during the same time period, but not changes on measures of MA use. Item analysis of the ASI drug scale showed that psychiatric severity predicted how troubled or bothered participants were by their drug us, how important they felt it was for them to get treatment, and the number of days they experienced drug problems. However, it did not predict the number days they used drugs in the past 30 days. These associations did not differ between study conditions, and they persisted when psychiatric severity and outcomes were compared across 4- and 6-month time periods.

conclusionsResults are among the first to track how changes in psychiatric severity over time are associated with changes in MA use and severity of drug problems. Treatment efforts targeting reduction of psychiatric symptoms among MA-dependent persons might be helpful in reducing the level of distress and problems associated with MA use but not how often it is used. There is a need for additional research describing the circumstances under which the experiences and perceptions of drug-related problems diverge from frequency of consumption.

Indexed as

Motivational InterviewingPsychiatric Status Rating ScalesAdultAmphetamine-Related DisordersCognitive Behavioral TherapyFemaleHumansMaleMethamphetamineModels, PsychologicalOutpatientsPsychotherapy, GroupSeverity of Illness IndexTime FactorsYoung AdultMethamphetamineDrug treatmentmethamphetaminemotivational interviewingpsychiatric severity

Identifiers

PMID25775225
PMCPMC4573376
OpenAlexW2009508071

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.